The agenda features a mix of clinical updates and lively debates on provocative scientific topics impacting the field, including emerging concepts and therapies in multiple myeloma, lymphoma, acute and chronic lymphocytic leukemia, myeloid malignancies, and much more.
Highlights
Lymphoma
Chronic Lymphocytic Leukemia
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia/ Myelodysplastic Syndrome
Multiple Myeloma
Engaging Debates
CNS Prophylaxis in Aggressive Lymphoma - Aggressive/ Futile
Should MRD+ Patients with AML Proceed with HSCT? Yes / No
Will ASCT Continue to Be the Standard of Care in Frontline Therapy? Yes / No